Jordi Gol i Gurina Foundation   Report issue

Foundation Phase 3 Phase 4
Founded: Barcelona Spain (1995)

Organization Overview

First Clinical Trial
2003
NCT00125905
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Foundation Jordi GOL | Idiap | IDIAP Jordi Gol | Jordi Gol i Gurina Foundation | Jordi Gol I Gurina Foundation-ICS | Mª Dolores Rodríguez Garrido | Victoria Arija Val

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Disease (Phase 4)

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Bronchitis (Phase 4)

Chronic Disease (Phase 4)

Molluscum Contagiosum (Phase 3)

Pneumonia (Phase 3)

Signs and Symptoms, Respiratory (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 14